Emphysema or COPD
31
12
13
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 31 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (31)
Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema
Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction
First in Human Study to Assess an Implant to Treat Severe Emphysema
Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema
A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Zephyr Etude Post-Inscription (French Registry)
PiMZ Longitudinal Cohort (PiMZ Logic)
Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Ultrasound and Respiratory Physiological Signals in Lung Diseases
Utilising Hull Lung Health Study Data to Investigate the Performance of TidalSense Diagnostic Algorithms to Identify COPD and Pre-COPD Among Participants in the FRONTIER Programme.
Anti-Platelets in Chronic Obstructive Pulmonary Disease
Post-Market BTVA Registry
The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema
Maximizing Benefit of Lung Cancer Screening Incidental Findings of Cardiovascular, Respiratory and Breast Measures
Healthy At Home Pilot
Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
Biological Investigation of Explanted Endobronchial Lung Valves Study